On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib
Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!! Read our latest press releases here: Progeria Research Foundation Announces Collaboration and Supply Agreement...
Night of Wonder 2018: Music to your ears!
Night of Wonder 2018: Music to your ears! Saturday Evening, April 28, 2018Renaissance Waterfront in Boston, MA PRF’s phenomenal 2018 Night of Wonder, signature gala & auction, was a huge success! We truly did Rock the Cure! TOGETHER we raised just over...
April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!
A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Get the news here: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with...
First Children Enroll to Complete Their Final Visit
